miR-370-3p as a Novel Biomarker Promotes Breast Cancer Progression by Targeting FBLN5

Figure 6

The detection of miR-370-3p expression in breast tissues, serum, and serum exosomes. (a) The levels of miR-370-3p in adjacent normal tissues and breast cancer tissues. . (b) The diagnostic values of miR-370-3p ROC curves in breast cancer tissues. (c) The correlation between the levels of miR-370-3p and clinicopathological parameters (lymph node metastasis) in breast cancer tissues. . (d) The expression of miR-370-3p in the serum of 28 healthy volunteers and that of 28 patients with breast cancer. . (e) The diagnostic values of miR-370-3p ROC curves in breast cancer serum. (f) The correlation between the levels of miR-370-3p and clinicopathological parameters (lymph node metastasis and TNM stage) in breast cancer serum. (g) The levels of miR-370-3p in the exosomes of serum in 28 healthy volunteers and that of 28 patients with breast cancer. . (h) The diagnostic values of miR-370-3p ROC curves in breast cancer serum exosomes. (i) The correlation between the levels of miR-370-3p and clinicopathological parameters (lymph node metastasis, tumor diameter, and TNM stage) in serum exosomes of breast cancer. . (j) The ROC curve of serum CA153.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)